volume 23, issue 3, P521-533 2009
DOI: 10.1016/j.idc.2009.04.004
View full text
|
|
Share
Emili Diaz, Marta Ulldemolins, Thiago Lisboa, Jordi Rello

Abstract: Ventilator-associated pneumonia (VAP) management depends on the interaction between the infective agent, the host response, and the antimicrobial drug used. After the pathogen reaches the lungs, two outcomes are possible: either the microorganisms are eliminated by the host immune system, or they overcome the immune system and cause pulmonary infection. When a patient is thought to have VAP, two steps are strongly recommended: etiologic diagnostic testing and the immediate initiation of antibiotics. The daily …

expand abstract